Cover Page -- Half Title -- Title -- Copyright -- Contents -- Foreword -- Preface -- Acknowledgments -- About the Author -- Abbreviations -- Chapter 1 Pharmaceutical Policy Goals -- Pharmaceutical Policy Framework -- Parameters for Monitoring the Effect and Progress of Pharmaceutical Reforms -- References -- Chapter 2 Introducing the Stakeholders -- Multinational Research-Based Companies -- Multinational Generics Companies -- National Generics Companies -- Brokers -- Procurement Agents -- Importers and Agents -- Wholesalers -- Central Medical Stores -- Retail Pharmacists and Drug Sellers -- Prescribers -- Consumers -- Public Policy Makers: Legislative and Executive -- Regulatory and Executive Agencies -- Expert Commissions and Advisers -- Civil Society Organizations -- International Agencies and Donors -- Public Purchasers -- Payers -- Pharmaceutical Benefit Managers -- Consultants -- Notes -- References -- Chapter 3 Patterns of Dysfunction -- Inadequate Regulation of Core Pharmaceutical Sector Functions -- Lack or Misuse of Funds -- Ineffective or Inefficient Procurement -- Dysfunctional Supply Chains -- Corruption, Abuse of Public Funds, and Unethical Business Practices -- Inadequate Incentives for Providers and Policy Makers -- Medicine Prices Perceived as Too High -- Conflicts between Innovation and Cost Containment -- Conflicts between Industrial Policy and Public Health Objectives -- Irrational or Inappropriate Use of Drugs -- A Tool to Assess the Sector and Diagnose Dysfunctions -- Notes -- References -- Chapter 4 Key Elements of a Successful Pharmaceutical Policy -- Ensuring Access to Safe and Effective Drugs through Well-Designed Supply Chains -- Using Purchasing Power to Get Value for Money -- Managing the Decision Process on Formulary Inclusion -- Creating Adequate Information Systems.

Ensuring Rational and Cost-Effective Use of Medicines -- Securing Adequate Financing and Payment Mechanism for Pharmaceuticals -- Reconciling Health Policy and Industrial Policy in the Pharmaceutical Sector -- Ensuring Good Governance of the Sector -- Notes -- References -- Chapter 5 Policy Packages to Achieve Strategic Long-Term Goals -- Essential Medicines Policy -- Generic Drugs Policy -- Innovation-Friendly Drugs Policy -- Combining Several Policy Models within One Country -- Notes -- Reference -- Chapter 6 Factors Influencing Policy Implementation -- Stakeholder Assessment and Involvement -- Strategies to Neutralize Political Opposition -- Note -- Reference -- Chapter 7 Pharmaceutical Policy Illustrated in Country Examples -- Ghana: National Health Insurance as a "Game Changer" -- Lithuania: Dealing with the Effects of the Financial Crisis -- China: Improving Social Protection for the Rural Poor -- Russian Federation: Affordability and Access to Essential Drugs -- Liberia: Building Up after Conflict -- Notes -- References -- Chapter 8 Pharmaceutical Policy Outlook -- Regulatory Framework -- Drug Prices -- Financing and Management of Drug Benefits -- Effect on Markets and Industry General Trend: Convergence toward Models -- That Work -- References -- Appendix A A Tool to Assess the Pharmaceutical Sector in a Given Country -- Appendix B Customized Version of the Assessment Tool (Appendix A) for Use in an Assessment of the Pharmaceutical Sector in Turkey -- Part 1: Quantitative Data -- Part 2: Descriptive Section -- Appendix C Assessment Tool for Government Procurement Agencies in the Health Sector in India -- Index.